India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

GlaxoSmithKline Pharmaceuticals Ltd.

Income Statement - Consolidated

Market Cap.(`)	50554.15 Cr.	P/BV	30.22	Book Value (`)	98.74
52 Week High/Low ( ` )	3148/1921	FV/ML	10/1	P/E(X)	54.50
Book Closure	30/05/2025	EPS (`)	54.75	Div Yield (%)	1.81

(` in Crs.)

You can view the Consolidated Income Statement for the last 5 years.

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	3749.21	3441.77	3226.38	3264.08	2895.75
Other Operating Revenues	0.00	11.94	25.34	13.95	29.86
Total Operating Revenues	3749.21	3453.71	3251.72	3278.03	2925.60

Other Income	145.93	122.59	100.66	75.78	110.58
Total Revenue	3895.14	3576.30	3352.38	3353.80	3036.18

EXPENSES
Cost Of Materials Consumed	499.90	545.17	427.49	611.18	471.78
Purchase Of Stock-In Trade	845.11	853.08	788.43	729.44	823.09
Operating And Direct Expenses	0.00	0.00	73.85	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	45.85	-63.72	68.96	15.57	-38.02
Employee Benefit Expenses	579.70	624.39	594.99	610.23	616.16
Finance Costs	1.31	1.80	1.81	2.00	3.53
Depreciation And Amortisation Expenses	66.79	69.68	65.77	68.19	78.60
Other Expenses	601.29	586.10	493.73	549.73	454.45
Total Expenses	2639.95	2616.50	2515.02	2586.33	2409.60

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	1255.19	959.80	837.37	767.47	626.59

Exceptional Items	4.69	-143.62	-0.97	11.58	-172.60
Profit/Loss Before Tax	1259.88	816.19	836.40	779.05	453.99

Tax Expenses-Continued Operations
Current Tax	332.30	237.59	247.13	219.74	158.67
Deferred Tax	0.00	-11.36	-18.37	-9.40	8.05
Tax For Earlier Years	0.00	0.00	0.00	187.94	0.00
Total Tax Expenses	332.30	226.23	228.76	398.28	166.72
Profit/Loss After Tax And Before ExtraOrdinary Items	927.58	589.96	607.64	380.77	287.27

Profit/Loss From Continuing Operations	927.58	589.96	607.64	380.77	287.27

Profit/Loss From Discontinuing Operations	0.00	0.00	4.13	1708.18	96.51
Total Tax Expenses Discontinuing Operations	0.00	0.00	1.08	394.23	25.63
Net Profit/Loss From Discontinuing Operations	0.00	0.00	3.04	1313.95	70.88
Profit/Loss For The Period	927.58	589.96	610.69	1694.72	358.15

Minority Interest	0.00	4.17	6.04	0.00	0.00
Consolidated Profit/Loss After MI And Associates	927.58	594.13	616.72	1694.72	358.15

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	54.52	41.14	36.08	99.29	31.35
Diluted EPS (Rs.)	54.76	34.83	36.05	100.04	21.14

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	542.10	1524.66	508.22	677.62

GlaxoSmithKline Pharmaceuticals Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	50554.15 Cr.	P/BV	30.22	Book Value (`)	98.74
52 Week High/Low ( ` )	3148/1921	FV/ML	10/1	P/E(X)	54.50
Book Closure	30/05/2025	EPS (`)	54.75	Div Yield (%)	1.81

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00
No. of Equity Shares (in Lacs)	1694.10	1694.06	1694.06	1694.06	1694.06

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	169.41	169.41	169.41	169.41	169.41
Total Share Capital	169.41	169.41	169.41	169.41	169.41

Reserves and Surplus	1781.90	1617.24	1573.54	2493.55	1308.85
Total Reserves and Surplus	1781.90	1617.24	1573.54	2493.55	1308.85
Employees Stock Options	0.00	-9.01	-1.68	0.00	0.00
Total Shareholders Funds	1951.31	1777.64	1741.27	2662.96	1478.26

NON-CURRENT LIABILITIES
Other Long Term Liabilities	2.49	6.57	4.14	9.68	22.31
Long Term Provisions	249.11	247.46	254.80	262.21	259.50
Total Non-Current Liabilities	251.60	254.03	258.94	271.89	281.81

CURRENT LIABILITIES
Short Term Borrowings	0.00	0.00	0.00	0.00	0.02
Trade Payables	708.26	625.41	427.79	570.55	466.13
Other Current Liabilities	780.50	506.02	480.79	799.90	613.80
Short Term Provisions	416.41	393.52	417.79	327.98	274.62
Total Current Liabilities	1905.17	1524.95	1326.37	1698.43	1354.58

Total Capital And Liabilities	4108.08	3556.62	3326.58	4633.28	3114.65

ASSETS
NON-CURRENT ASSETS
Tangible Assets	270.32	297.72	295.87	296.15	343.55
Intangible Assets	13.33	23.55	34.09	34.50	43.36
Capital Work-In-Progress	14.32	13.93	20.31	30.50	13.21
Fixed Assets	297.97	335.20	350.27	361.15	400.12
Deferred Tax Assets [Net]	140.87	146.31	133.55	113.15	103.13
Long Term Loans And Advances	0.00	0.00	70.00	190.00	0.00
Other Non-Current Assets	259.35	276.68	278.50	260.95	408.76
Total Non-Current Assets	698.19	758.20	832.32	925.25	912.01


CURRENT ASSETS
Current Investments	1118.25	813.22	518.29	365.59	0.00
Inventories	481.74	525.05	459.97	534.70	546.70
Trade Receivables	292.55	222.06	192.38	205.24	215.60
Cash And Cash Equivalents	1403.52	1063.22	1155.93	2484.51	1157.96
OtherCurrentAssets	113.83	174.87	167.70	118.00	282.37
Total Current Assets	3409.89	2798.42	2494.26	3708.03	2202.64

Total Assets	4108.08	3556.62	3326.58	4633.28	3114.65

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	387.14	361.80	368.97	498.50

BONUS DETAILS
Bonus Equity Share Capital	0.00	125.39	125.39	125.39	125.39

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

GlaxoSmithKline Pharmaceuticals Ltd.

Income Statement - Consolidated

GlaxoSmithKline Pharmaceuticals Ltd.

Balance Sheet - Consolidated